Salignostics

About:

Salignostics operates as an R&D company that focuses on the development of saliva based rapid diagnostics tests.

Description:

Salignostics operates as an R&D company that focuses on the development of saliva based rapid diagnostics tests (RDT), utilizing a lateral flow immunoassay platform. The company is headquartered in Jerusalem, Jerusalem.

Total Funding Amount:

$8M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Jerusalem, Yerushalayim, Israel

Founded Date:

2016-01-01

Contact Email:

office(AT)salignostics.com

Founders:

Aaron Palmon, Guy Krief, Omer Deutsch, Raluca Cohen, Yoav Neumann

Number of Employees:

11-50

Last Funding Date:

2022-04-14

IPO Status:

Private

Industries: